NeuroPace Inc
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
NPCE$12.69-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Stockholders' Equity
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Total Stockholders’ Equity | |||||
|---|---|---|---|---|---|
| (in thousands, except share amounts) · Shares · Amount | |||||
| Balances as of January 1, 2025 | 30,145,039 | $30 | $538,933 | $(530,950) | $8,013 |
| Net loss | — | — | — | (6,589) | (6,589) |
| Issuance of ordinary shares in follow-on offering, net of underwriting discounts and commissions and offering expenses of $5,365 | 7,475,000 | 7 | 69,377 | — | 69,384 |
| Repurchase of common stock from KCK Ltd. | (5,270,845) | (5) | (49,541) | — | (49,546) |
| Issuance of common stock as part of At-the-Market offering, net of sales commission and offering expenses of $15 | 18,590 | — | 224 | — | 224 |
| Issuance of common stock pursuant to stock option exercises | 101,301 | 1 | 384 | — | 385 |
| Issuance of common stock upon vesting of restricted stock units | 299,535 | — | — | — | — |
| Shares withheld for taxes | (17,380) | — | (228) | — | (228) |
| Stock-based compensation | — | — | 2,626 | — | 2,626 |
| Balances as of March 31, 2025 | 32,751,240 | $33 | $561,775 | $(537,539) | $24,269 |
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Total Stockholders’ Equity | |||||
|---|---|---|---|---|---|
| (in thousands, except share amounts) · Shares · Amount | |||||
| Balances as of January 1, 2024 | 27,823,465 | $28 | $524,435 | $(503,809) | $20,654 |
| Net loss | — | — | — | (8,925) | (8,925) |
| Issuance of common stock pursuant to stock option exercises | 409,045 | — | 721 | — | 721 |
| Issuance of common stock upon vesting of restricted stock units | 522,483 | 1 | (1) | — | — |
| Shares withheld for taxes | (37,541) | — | (649) | — | (649) |
| Stock-based compensation | — | — | 2,540 | — | 2,540 |
| Balances as of March 31, 2024 | 28,717,452 | $29 | $527,046 | $(512,734) | $14,341 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.